RUC. Repositorio da Universidade da Coruña
Publicación
Artículo científico (JournalArticle)
Polymer Coating Adhesion Drives Functional and Biological Outcomes in Meniscus Implants
[Abstract]: Achieving stable integration of drug-releasing polymer coatings with load-bearing meniscus implants remains a challenge in biomaterials engineering. In this study, four surface modification strategies, femtosecond-pulsed laser treatment, oxygen plasma, polydopamine, and an ethyl-2-cyanoacrylate (ECA) interlayer, were evaluated for the integration of a dexamethasone (DEX)- and celecoxib (CLX)-releasing bilayer coating with a polycarbonate urethane (PCU) meniscus implant. The selected construct comprised an ECA interlayer applied from a 40% (w/v) solution, a CLX-loaded PLLA/PCL layer prepared at 100 mg/mL and a 53/47 (w/w) polymer ratio with 16.6% CLX loading, and an outer DEX-loaded PLGA layer prepared at 200 mg/mL with 2.44% DEX loading. At 37 °C, compared with uncoated PCU, ECA-containing constructs showed significantly higher storage modulus, loss modulus, and elastic modulus (p < 0.05), while tan δ remained unchanged, indicating preservation of the elastic-dominant viscoelastic response of the complete construct. The ECA-containing coating was subsequently adapted to the geometry of a sheep meniscus implant using an optimized dip-coating procedure. During a 21-day bioreactor study, repeated compression and shear increased cumulative DEX release from 59 to 67% and CLX release from 25 to 40% relative to static controls, while no visible
coating delamination was observed. Ethylene oxide sterilization preserved drug loading and release behavior. In an exploratory threemonth sheep study, the fiber-fixed coated implants remained in position, and the coating remained macroscopically associated with the retrieved prostheses. These findings support the use of an ECA interlayer to integrate a bilayer drug-releasing coating with a PCU meniscus implant while preserving construct-level mechanical behavior and drug release under the conditions evaluated., This project has received funding from the European Union’s Horizon 2020 research and innovation program under Grant Agreement No. 814444 (MEFISTO). Alfonso F. Blanco has received research support through a predoctoral grant from Xunta de Galicia, Grant No. ED481A 2022/066. Inés RubioPrego acknowledges a grant (IFI23/00035) from Instituto de Salud Carlos III “Contratos i-PFIS: Doctorados IIS-empresa en Ciencias y Tecnologías de la Salud”. Carmen Bao-Varela acknowledges financial support under grant PID2022- 138322OB-100 funded by MCIN/ AEI/ 10.13039/ 501100011033 and by “ERDF A way of making Europe” and the support of Xunta under grant ED431B 2023/07. The graphical artwork was created by the authors. BioRender (www.biorender.com) was used as a graphical design tool for the figures indicated in the corresponding captions., Xunta de Galicia; ED481A 2022/066, Xunta de Galicia; ED431B 2023/07